New Lifesaving Blood Cancer Drug OKd

Thursday, 07 Mar 2013 09:28 AM

 

  Comment  |
   Contact  |
  Print   |
    A   A  
  Copy Shortlink
Pomalyst (pomalidomide) has been approved by the FDA to treat cases of multiple myeloma that have not responded to other therapies.

The disease, a form of blood cancer, affects some 21,700 Americans annually and nearly 10,700 die from it each year, the agency said Friday in a news release.

Pomalyst is designed to spur the immune system to destroy and inhibit cancer cells, the FDA said. The drug's safety and effectiveness were evaluated in a clinical study of 221 people with advanced multiple myeloma.

Obamacare
: Massive New Rules Revealed for 2013

The drug's label will contain a boxed warning that it shouldn't be used by pregnant women since it can cause life-threatening birth defects and blood clots, the FDA said.

More common side effects could include a drop in infection-fighting white blood cells, fatigue, weakness, other blood disorders, back pain and fever.

The drug is marketed by Celgene, based in Summit, N.J.

© HealthDay

  Comment  |
   Contact  |
  Print   |
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Drug Fights Antibiotic-Resistant Infection

Saturday, 20 Dec 2014 10:33 AM

Cubist Pharmaceutical drug to treat complicated urinary tract and intra-abdominal infections won U.S. approval on Friday . . .

New Help Against Ovarian Cancer

Friday, 19 Dec 2014 15:48 PM

The U.S. Food and Drug Administration has approved a new drug to treat advanced ovarian cancer, along with a test to ide . . .

Device Makes Blood Transfusions Safer

Wednesday, 17 Dec 2014 13:08 PM

U.S.health regulators on Tuesday approved a device developed by Cerus to reduce the risk of infections in blood plasma t . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved